DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial
Titel:
DNA epigenetic signature predictive of benefit from neoadjuvant chemotherapy in oesophageal adenocarcinoma: results from the MRC OE02 trial
Auteur:
Sundar, Raghav Ng, Alvin Zouridis, Hermioni Padmanabhan, Nisha Sheng, Taotao Zhang, Shenli Lee, Ming Hui Ooi, Wen Fong Qamra, Aditi Inam, Imran Hewitt, Lindsay C. So, Jimmy Bok-Yan Koh, Vivien Nankivell, Matthew G. Langley, Ruth E. Allum, William H. Cunningham, David Rozen, Steven G. Yong, Wei Peng Grabsch, Heike I. Tan, Patrick